Macquarie Group LTD Vbi Vaccines Inc Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $1,546 - $49,584	-2,119 Reduced 11.13%	16,926 $13,000
Q4 2021 Feb 11, 2022	SELL	$2.21 - $3.22 $17,562 - $25,589	-7,947 Reduced 29.44%	19,045 $45,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $47,392 - $62,964	16,926 Added 168.15%	26,992 $84,000
Q2 2021 Aug 13, 2021	SELL	$2.61 - $4.17 $3,552 - $5,675	-1,361 Reduced 11.91%	10,066 $34,000
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $33,252 - $49,364	11,427 New	11,427 $36,000
Q1 2018 May 11, 2018	SELL	$3.5 - $4.47 $7,350 - $9,387	-2,100 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$3.29 - $5.03 $6,909 - $10,563	2,100	2,100 $9,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.